Jon Olav Ødegård • 1973 • Oslo • 15 roles • 6 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
Ø ØDEGÅRD PROSJEKT AS	Managing Director/CEO	-	3,077,173	100 % directly
B BRILLIANT INVEST AS	Managing Director/CEO	-	-5,070,036	7.82 % indirectly
H HBC BERKÅK AS	Managing Director/CEO	575,309	-23,546,713	0.77 % indirectly
H HOFSETH BIOCARE ASA	Managing Director/CEO	218,418,000	74,612,000	0.77 % indirectly
H HBC THERAPEUTICS AS	Managing Director/CEO	-	-289,271	0.77 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
Ø ØDEGÅRD PROSJEKT AS	Chairman	-	3,077,173	100 % directly
G GREEN ALKANE TECHNOLOGIES AS	Chairman	-	13,702	30 % indirectly
B BRILLIANT INVEST AS	Chairman	-	-5,070,036	7.82 % indirectly
H HBC BERKÅK AS	Chairman	575,309	-23,546,713	0.77 % indirectly
H HBC THERAPEUTICS AS	Chairman	-	-289,271	0.77 % indirectly
H HOFSETH BIOCARE RØRVIK AS	Chairman	-	-1,414,926	-
A AQUA BIO TECHNOLOGY ASA	Chairman	516,293	62,722,660	-
K KILDA BIOLINK AS	Board Member	-	-5,232,687	-
B BOMI FRAMROZE HOLDING AS	Contact Person	-	179,890	-

Last update: Dec 31, 2024

Shares owned by Jon Olav Ødegård

Name	Share class	Total operating income	Total equity	Share
Ø ØDEGÅRD PROSJEKT AS	Ordinære aksjer	0	3,077,173	100 % directly
G GREEN ALKANE TECHNOLOGIES AS		0	13,702	30 % indirectly
B BRILLIANT INVEST AS		0	-5,070,036	7.82 % indirectly
H HBC BERKÅK AS		575,309	-23,546,713	0.77 % indirectly
H HOFSETH BIOCARE ASA		218,418,000	74,612,000	0.77 % indirectly
H HBC THERAPEUTICS AS		0	-289,271	0.77 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024